VITAMIN B 12 OR COBALAMIN DEFICIENCY occurs frequently (> 20%) among elderly people,
but it is often unrecognized because the clinical manifestations are subtle; they are also …

… Maloisel are recipients of a grant from the Laboratoire CHUGAI, but this sponsor had no
part in the research or writing of the present manuscript. … 28 Maloisel F, Andrès E …

Background Treatment with interferon prolongs survival in chronic myelogenous leukemia.
We conducted a clinical trial to assess the efficacy of treatment with a combination of …

… Jean-Luc Harousseau, Michel Attal, Hervé Avet-Loiseau, Gerald Marit, Denis Caillot,
Mohamad Mohty, Pascal Lenain, Cyrille Hulin, Thierry Facon, Philippe Casassus, Mauricette …

High-dose therapy has become a common treatment for myeloma. The objective of this study
(Intergroupe Francophone du Myélome [IFM] 9502 trial) was to compare in a prospective …

Objective: In this article, we report and discuss the clinical presentation and management of
idiosyncratic drug-induced agranulocytosis (neutrophil count <0.5 × 10 9 /l). Results/…

The occurrence of non-Hodgkin's lymphoma (NHL) is the most serious complication of
Sjögren's syndrome (SS). We performed a study of 16 NHLs occurring in patients with an …

PURPOSE: Approximately 15% of people aged more than 60 years old have a cobalamin (vitamin
B12) deficiency, mainly in relation with food-cobalamin malabsorption (FCM). To date, …

In myelodysplastic syndromes (MDS), anemia responds to recombinant human
erythropoietin (rHuEPO) alone and in combination with recombinant human granulocyte-colony-…

Because interleukin-6 (IL-6) is considered important in the proliferation of early multiple
myeloma (MM), we hypothesized that the addition of the anti-IL-6 monoclonal antibody …